January 30, 2012 – Investors in the Series A round included CTI Life Sciences Fund L.P., Qiagen N.V. and Ontario Capital Growth Corporation through its Emerging Technologies Fund.
Category: Uncategorized
Triphase Accelerator Corporation Announces Expansion of Collaboration with Celgene
May 3, 0206 – Triphase is expanding its current collaboration with Celgene in the development of marizomib for the potential treatment of malignant gliomas.
Read More from Triphase Accelerator Corporation Announces Expansion of Collaboration with Celgene